General MedicationsOPHTHALMICStandard
TISSUEBLUE
BRILLIANT BLUE G
Standard Dose
0.025%
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary
Approval overview TISSUEBLUE is listed in Drugs@FDA under application 209569 (NDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient BRILLIANT BLUE G Form and strength SOLUTION;OPHTHALMIC - 0.025% Sponsor DUTCH OPHTHALMIC Submission history Latest submission status date: 2025-04-04 00:00:00.
Structured Monograph
Clinical summary
Approval overview TISSUEBLUE is listed in Drugs@FDA under application 209569 (NDA). Review priority: STANDARD Marketing status: Prescription Active ingredient BRILLIANT BLUE G Form and strength SOLUTION;OPHTHALMIC - 0.025% Sponsor DUTCH OPHTHALMIC Submission history Latest submission status date: 2025-04-04 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.